Clinical Research Directory
Browse clinical research sites, groups, and studies.
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Sponsor: Biotheus Inc.
Summary
This study is to characterize the safety, tolerability, pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD) and anti-tumor activity of PM8002, a PD-L1/VEGF bispecific antibody, as a single agent in adult subjects with advanced solid tumors.
Official title: Phase Ib/IIa Safety and Efficacy of PM8002, a Bispecific Antibody Targeting PD-L1 and VEGF-A, as a Monotherapy in Patients With Advanced Solid Tumors
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
380
Start Date
2021-03-09
Completion Date
2025-11-30
Last Updated
2024-12-05
Healthy Volunteers
No
Conditions
Interventions
PM8002
IV infusion
Locations (48)
Baoji Central Hospital
Baoji, China
Baoji Central Hospital
Baoji, China
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Peking University Cancer Hospital
Beijing, China
Peking University Cancer Hospital
Beijing, China
Jilin Cancer Hospital
Changchun, China
The First Hospital of Jilin University
Changchun, China
Changde First People's Hospital
Changde, China
Hunan Provincial People's Hospital
Changsha, China
The First People's Hospital of Changzhou
Changzhou, China
Chengdu Integrated TCM& Western Medicine Hospital
Chengdu, China
Sichuan Cancer Hospital
Chengdu, China
Chongqing Cancer Hospital
Chongqing, China
Chongqing Cancer Hospital
Chongqing, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
The Southwest Hospital of AMU
Chongqing, China
Fujian Cancer Hospital
Fuzhou, China
Fujian Cancer Hospital
Fuzhou, China
Zhejiang Provincial People's Hospital
Hangzhou, China
Harbin Medical University Cancer Hospital
Harbin, China
Anhui Provincial Hospital
Hefei, China
Linyi Cancer Hospital
Linyi, China
Jiangsu Province Hospital
Nanjing, China
Jiangsu Province Hospital
Nanjing, China
Shanghai Orient Hospital
Shanghai, China
Shanghai Sixth People's Hospital
Shanghai, China
Shengjing Hospital of China Medical University
Shengjing, China
Liaoning Cancer Hospital
Shenyang, China
The First Hospital of China Medical University
Shenyang, China
The People's Hospital of Liaoning Province
Shenyang, China
The Fourth Hospital of Hebei Medical University
Shijiazhuang, China
Shanxi Bethune Hospital
Taiyuan, China
Shanxi Provincial Cancer Hospital
Taiyuan, China
Shanxi Provincial Cancer Hospital
Taiyuan, China
Taizhou Hospital of Zhejiang Province
Taizhou, China
The Second Hospital of Tianjin Medical University
Tianjin, China
Hubei Cancer Hospital
Wuhan, China
Hubei Cancer Hospital
Wuhan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
Xi 'an International Medical Center Hospital
Xi'an, China
Xi 'an International Medical Center Hospital
Xi'an, China
Yantai Yuhuangding Hospital
Yantai, China
Yibin Second People's Hospital
Yibin, China
Henan Cancer Hospital
Zhengzhou, China
The first affilated hospital of zhengzhou university
Zhengzhou, China
The first affilated hospital of zhengzhou university
Zhengzhou, China
Zhujiang Hospital of Southern Medical University
Zhujiang, China